medigraphic.com
ISSN 0210-5187 (Electronic)

2006, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2006; 34 (1)

Drug hypersensitivity syndrome to sulfasalazine in an HIV patient

Corral CM, Arranz SD, Herranz PP, Díaz DR, Martín DMA, Casado JM

Language: Spanish
References: 28
Page: 17-20
PDF size: 207.64 Kb.


ABSTRACT

Drug hypersensitivity syndrome is defined by the clinical triad of fever, rash, and internal organ involvement.
Numerous drugs have been associated with isolated cutaneous eruptions (particularly of the simple exanthematic or maculopapular type), while only a limited number of drugs are associated with drug hypersensitivity syndrome. Drugs commonly associated with drug hipersensitivity syndrome include the anticonvulsants, antibiotics, sulfasalazines and antiretrovirals.
Despite the numerous drug reactions described in HIV patients, up to our knowledge, this is the first case, of drug hypersensitivity syndrome to sulfasalazines in an HIV patient has not been previously reported.


REFERENCES

  1. Pérez Pimiento AJ, Calvo Manuel E, Lozano Tonkin C, Espinós Pérez D. Síndrome de hipersensibilidad retardada a fármacos. Rev Clin Esp 2002;202:339-46.

  2. Spielberg SP, Shear NH, Cannon M, Hutson NJ, GudersonK. In vitro assesment of a hypersensitivity syndrome associated with sorbinel. Ann Intern Med 1991;114:720-4.

  3. Schlienger R, Shear N. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998;39:S3-7.

  4. Coopman SA, Johnson RA, Platt R, Stern R. Cutaneous disease and drugs reactions in HIV infection. N Engl J Med 1993;328:1670-4.

  5. Koopmans PP, Van der ven AJAM, Vreet B, Van der Meer JWM. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic?. AIDS 1995;9:217-22.

  6. Burman W, Orr L. Carbamazepine toxicity after starting combination antiretroviral therapy including ritonavir and efavirenz. AIDS 2000;14:2793-4.

  7. Fuentes A, Otero MJ. Interacciones de los fármacos antirretrovirales. Med Clin (Barc) 1999;113:94-102.

  8. Pakianathan MR, Kamarulzaman A, Ismail R, Mc Millan A, Scott GR. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients. AIDS 1999;13:1787-8.

  9. Beller TC, Boyce JA. Prolonged anticonvulsant hypersensitivity syndrome related to lamotrigine in patient with HIV. Allergy Asthma Proc. 2002;23:415-9.

  10. Sissoko D, Ajana F, de la Tribonniere X, Baclet V, Monton Y. Cutaneous, hepátic and hematologic manifestations due to nevirapine: DRESS síndrome?. Presse Med. 2000;29:1014-2.

  11. Sibaud V, Billon C, Barcat D, Bernard N, Geniaux M. Hypersensitivity syndrome to nevirapine. Therapie 2000;55:320-2.

  12. Fernandez-Chico N, Bielsa Marsal I. Síndrome de hipersensibilidad a fármacos. Piel 2003;18:252-8.

  13. Hewitt RG. Abacair hipesensitivity reaction. CID 2002;34:1137-42.

  14. Wassef M, Keiser P. Hypersensitivity to zidovudine: report of a case of anaphylaxis and review of the literature. Clin Infect Dis 1995;20:1387-9.

  15. Herranz P, Fernández-Díaz ML, Lucas R, González García J, Casado M. Cutaneous vaculitis associated with didanosine. Lancet 1994;344:680.

  16. Tancrede-Bohin E, Range F, Bournerias I, Roujeau JC, Guillaume JC. Hypersensitivity syndrome associated with zalcitabine therapy. Lancet 1996;347:971.

  17. Demeter LM, Shafer RW, Meehan PM, Holden-Wiltse J, Fischl MA, Freimuth WW, et al: Delavirdine susceptibilities and associated reverse transcriptase mutations in human immuno-deficiency virus type 1 isolates from patients in a phaseI/II trial of delavirdine monotherapy (ACTG 260). Antimicrob Agents Chemother 2000;44:794-7.

  18. Bourezane Y, Salard D, Hoen B, Vandel S, Drobacheff C, Laurent R. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated withneirapine therapy. Clin Infect Dis 1998;27:1321-2.

  19. Bossi P, Colin D, Bricaire F, Caumes E. Hypersensitivity syndrome associated with efairenz therapy. Clin Infect Dis 2000;30:227-8.

  20. Goodgame JC, Pottage JC Jr, Jablonowski H, Hardy WD, Stein A, Fischl M, et al. Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1 infected antiretroviral naïve adults. Antivir Ther 2000;5:215-25.

  21. Muñoz Fernández S, Hidalgo V, Fernández-Melón J, Schlincker A, Bonilla G, Ruiz-Sancho D, Fonseca A, Gijón-Baños J, Martín-Mola E. Sulfasalazine reduces the number of flares of acute anterior uveitis over a one year period. J Rheumatol 2003;30:1277-9.

  22. Borrás-Blasco J, Navarro-Ruiz A, Matarredona J, Devesa P, Montesinos-Ros A, González-Delgado M. Photo-induced stevens-johnson syndrome due to sulfasalazine therapy. Ann Phamacother 2003;37;1241-43.

  23. Ribe J, Benkov KJ, Thung SN, Shen SC, LeLeiko NS. Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine. Am J Gastroenterol 1986;81:205-8.

  24. Marinos G, Riley J, Painter DM, McCaughan GW. Sulfasalazine-induced fulminant hepatic failure. J Clin Gastroenterol. 1992;14:132-5.

  25. Kunisaki Y, Goto H, Kitagawa K, Nagano M. Salazosulfapyridine induced hypersensitivity syndrome associated with reactivation of humanherpes virus 6. Intern Med. 2003;42:203-7.

  26. Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, Belaich S, Crickx B. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.

  27. Tohyama M, Tahaa Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, Hashimoto K. Severe hypersensitivity síndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998;134:1113-7.

  28. Ohtani T, Hiroi A, Sakurane M, Furukawa F. Slow acetylator genotypes as a possible risk factor for nfectious mononucleosis-like syndrome induced by salazosulfapyridine. Br J Dermatol 2003;148:1035-9.




2020     |     www.medigraphic.com